Although the TIMER immunoassay database showed that CASP4 is closely associated with dendritic cells in glioma patients, the percentage of dendritic cells in glioma immune cells, as revealed by the CIBERSORT algorithm, is very small. This evidence concerns the gene CASP4 and central nervous system cancer.